Working... Menu
Trial record 7 of 2537 for:    hyperinsulinism

Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00674440
Recruitment Status : Completed
First Posted : May 7, 2008
Last Update Posted : February 19, 2018
University of Pennsylvania
Information provided by (Responsible Party):
Lisa States, Children's Hospital of Philadelphia

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : February 2018
  Certification/Extension First Submitted : January 25, 2013
Publications of Results:

Other Publications: